Shrikant Chouhan, Head of Equity Research at Kotak Securities, has recommended buying shares of Emcure Pharmaceuticals and ...

The stock has gained 52.76 per cent over the last six months but remains down 1.84 per cent year-to-date (YTD).

A pharmaceutical stock gained nearly five percent, following news of a strategic acquisition. Investors reacted positively as the company moved to consolidate its stake in a key subsidiary, reflecting ...

Indian frontline indices gained nearly 1% on October 6, with the Nifty 50 closing at 25,077 and the Sensex at 81,709. IT, ...

Bombay Burmah Trading Corporation Ltd clocked volume of 7.18 lakh shares by 14:14 IST on NSE, a 20.24 times surge over two-week average daily volume of 35466 shares ...

CHENNAI: Indian equity markets ended Monday’s session on a strong note, driven by firm gains in banking, healthcare, and information technology stocks. Investor ...

Nifty, Sensex near day’s high. Banking and financial heavyweights post robust quarterly results. Kotak, Axis Bank & HDFC Bank ...

Two Indian generic drugmakers – Hetero and Dr Reddy’s – will be funded by the Gates Foundation and Unitaid, respectively, to ...

Indian markets rose for the third session, led by strong gains in banking, financials, and IT ahead of Q2 earnings. Nifty reclaimed the 25,000 mark, supported by upbeat loan growth data and improving ...

After a promising start, biotech IPOs all but fizzled out this year, but LB Pharmaceuticals is hoping that won't stymy its chances of completing a Nasdaq listing. New York-based LB is hoping to raise ...